E-Book, Englisch, 253 Seiten
Dittus Novel Therapeutics for Rare Lymphomas
1. Auflage 2019
ISBN: 978-3-030-25610-4
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
E-Book, Englisch, 253 Seiten
ISBN: 978-3-030-25610-4
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.
Christopher Dittus, DO, MPHAssistant Professor of Medicine
Division of Hematology/Oncology, Lymphoma Program University of North Carolina, Chapel Hill
